Treatment for diabetes in patients with insufficient glycemic control despite therapy… Grant US-11911388-B2 United States of America 27 Feb 2024
Vasoprotective and cardioprotective antidiabetic therapy Grant US-11911387-B2 United States of America 27 Feb 2024
Acute treatment and rapid treatment of headache using anti-CGRP antibodies Grant US-11639380-B2 United States of America 02 May 2023
Treatment of headache using anti-CGRP antibodies Grant US-11639381-B2 United States of America 02 May 2023
Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or… Grant US-11325967-B2 United States of America 10 May 2022
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with… Grant US-11027018-B2 United States of America 08 Jun 2021
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such… Grant US-10973827-B2 United States of America 13 Apr 2021
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with… Grant US-10765746-B2 United States of America 08 Sep 2020
Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or… Grant US-10266587-B2 United States of America 23 Apr 2019
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as… Grant US-10202383-B2 United States of America 12 Feb 2019
Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome Grant US-10195203-B2 United States of America 05 Feb 2019
Medical use of pharmaceutical combination or composition Grant US-10155000-B2 United States of America 18 Dec 2018
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin Grant US-10092571-B2 United States of America 09 Oct 2018
Treatment for diabetes in patients inappropriate for metformin therapy Grant US-10034877-B2 United States of America 31 Jul 2018
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as… Grant US-10023574-B2 United States of America 17 Jul 2018
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such… Grant US-10022379-B2 United States of America 17 Jul 2018
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with… Grant US-9855332-B2 United States of America 02 Jan 2018
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines Grant US-9751855-B2 United States of America 05 Sep 2017
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as… Grant US-9556175-B2 United States of America 31 Jan 2017
Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome Grant US-9526730-B2 United States of America 27 Dec 2016
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such… Grant US-9415016-B2 United States of America 16 Aug 2016
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as… Grant US-9321791-B2 United States of America 26 Apr 2016
REGULATION OF GLUCOSE METABOLISM USING ANTI-CGRP ANTIBODIES Application WO-2015003122-A2 World Intellectual Property Organisation (WIPO) 08 Jan 2015
ANTIDIABETIC MEDICATIONS COMPRISING A DPP-4 INHIBITOR (LINAGLIPTIN) OPTIONALLY IN… Application US-20120094894-A1 United States of America 19 Apr 2012